Table 1.
Clinical burden of CAD.
| Smolderen 2012a | Smolderen 2012a | Smolderen 2010b | |
|---|---|---|---|
| Country | France | Germany | Canada |
| Condition | CAD | CAD | CAD |
| Registry | REACH | REACH | REACH |
| Cohort size | 2473 | 3510 | 1362 |
| Age (mean) | 69.1 | 68.0 | 68.3 |
| Non-fatal events (per 1000 patients) |
|||
| Non-fatal stroke | 24.0 | 29.5 | 8.1 |
| TIA | 8.4 | 17.2 | 6.6 |
| Non-fatal MI | 20.4 | 17.5 | 9.6 |
| Unstable angina | 49.2 | 102.3 | 39.8 |
| CHF | 46.1 | 64.2 | 14.0 |
| CABG | 8.4 | 27.8 | 19.2 |
| PCI/Stenting | 55.0 | 84.7 | 29.5 |
aEvent rates per 1000 patients over 2 years.
bEvent rates per 100 patients over 1 year.
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CHF, chronic heart failure; MI, myocardial infarction; PCI, percutaneous coronary intervention; TIA, transient ischemic attack; REACH, Reduction of Atherothrombosis for Continued Health.